The LAM-SAFE Study: Lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults

Seizure

Volumn 14, Issue 8, 2005, Pages 597-605

  Steinhoff, Bernhard J ^a,g   Ueberall, Michael A ^b,g   Siemes, Hartmut ^c   Kurlemann, Gerd ^d   Schmitz, Bettina ^e,g   Bergmann, Lars ^f   Baier, ^g   Bredel Geissler, ^g   Brockman, ^g   Christe, ^g   Haberl, ^g   Hause, ^g   Helmchen, ^g   Keimer, ^g   Meencke, ^g   Meierkord, ^g   Mullner ^g   Neumann, ^g   Noachtar, ^g   Paulus, ^g   Schumann, ^g   Sigel, ^g   Spohr, ^g   Stephan, ^g   Stodieck, ^g   Weiller, ^g   Wolff, ^g   more..

^a Epilepsiezentrum Kork   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Neurologisches Rehabilitationszentrum für Kinder und Jugendliche   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f GLAXOSMITHKLINE   (Germany)

^g NONE

Author keywords

Carbamazepine; Comparative trial; Lamotrigine; Monotherapy; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; LAMOTRIGINE; TIMONIL RETARD; VALPROIC ACID;

ADOLESCENT; ADULT; ALOPECIA; AMNESIA; ARTICLE; ASTROCYTOMA; ATAXIA; BODY WEIGHT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; EMOTIONAL DISORDER; FATIGUE; FEMALE; FOCAL EPILEPSY; GAIT DISORDER; GENERALIZED EPILEPSY; HEPATITIS; HUMAN; HYPONATREMIA; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; MUSCLE WEAKNESS; NAUSEA; NERVOUSNESS; OPEN STUDY; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; SEIZURE; SLEEP DISORDER; TREMOR; WEIGHT GAIN;

EID: 29044444974     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2005.09.011     Document Type: Article

References (31)

1. P. Kwan M.J. Brodie Early identification of refractory epilepsy N Engl J Med 342 2000 314-319
2. M.J. Brodie A. Richens A.W.C. Yuen Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy Lancet 345 1995 476-479
3. T.J. Steiner C.L. Dellaportas L.J. Findley M. Gross F.B. Gibberd G.D. Perkin D.M. Park R. Abbott Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin Epilepsia 40 1999 601-607
4. V. Biton W. Mirza G. Montouris A. Vuong A.E. Hammer P.S. Barret Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy Neurology 56 2001 172-177
5. M.J. Brodie P.W. Overstall L. Giorgi The UK Lamotrigine Elderly Study Group Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy Epilepsy Res 37 1999 81-87
6. R.H. Mattson J.A. Cramer J.F. Collins D.B. Smith A.V. Elgado-Escueta T.R. Browne et al. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures N Engl J Med 313 1985 145-151
7. R.H. Mattson J.A. Cramer J.F. Collins The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group A comparison of valproate with carbamazepine for the treatment of complex partial and secondarily generalized tonic-clonic seizures in adults N Engl J Med 327 1992 765-771
8. R.G. Beran S.F. Berkovic F.M. Dunagan F.J. Vajda G. Danta A.B. Black R. Mackenzie Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy Epilepsia 39 1998 1329-1333
9. T. Lerman-Sagie P. Lerman Dramatic effect of lamotrigine in young adults suffering from intractable absences and generalized tonic-clonic seizures since childhood J Epilepsy 11 1998 148-151
10. L.M. Frank T. Enlow G.L. Holmes P. Manasco S. Concannon C. Chen G. Womble E.J. Casale Lamictal (lamotrigine) monotherapy for typical absence seizures in children Epilepsia 40 1999 973-979
11. J.I. Morrow J.J. Craig A.J.C. Russell B. Irwin E. Guthrie P. Morrison et al. Which antiepileptic drugs are safest in pregnancy? Epilepsia 44 Suppl. 8 2003 P096 [Abstract]
12. M.D. Privitera M.J. Brodie R.H. Mattson D.W. Chadwick W. Neto S. Wang EPMN 105 Study Group Topiramate, carbamazepine and valproate monotherapy: Double-blind comparison in newly diagnosed epilepsy Acta Neurol Scand 107 2003 165-175
13. A. Richens A.W.C. Yuen Overview of the clinical efficacy of lamotrigine Epilepsia 32 Suppl. 2 1991 S13-S16
14. J.W.A.S. Sander Y.M. Hart P.N. Patsalos J.S. Duncan S.D. Shorvon Lamotrigine and generalized seizures Epilepsia 132 Suppl. 1 1991 59 [Abstract]
15. P.L. Timmings A. Richens Lamotrigine in primary generalised epilepsy Lancet 339 1992 1300-1301
16. E. Schlumberger F. Chavez L. Palacios E. Rey N. Pajot O. Dulac Lamotrigine in treatment of 120 children with epilepsy Epilepsia 35 1994 359-367
17. P. Uvebrant R. Bauziene Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits Neuropediatrics 25 1994 284-289
18. F.M.C. Besag S.J. Wallace O. Dulac J. Alving S.C. Spencer G. Hosking Lamotrigine in the treatment of epilepsy in childhood J Pediatr 127 1995 991-997
19. R. Ayala E.J. Casale G.A. Brookins P. Manasco The effectiveness and safety of Lamictal (lamotrigine) monotherapy for the treatment of newly diagnosed typical absence seizures in children and adolescents Epilepsia 37 Suppl. 5 1996 S165 [Abstract]
20. N. Buchanan The use of lamotrigine in juvenile myoclonic epilepsy Seizure 5 1996 149-151
21. O. Dulac A. Kaminska Use of lamotrigine in Lennox-Gastaut and related epilepsy syndromes J Child Neurol 12 Suppl. 1 1997 S23-S28
22. S. Buoni S. Grosso A. Fois Lamotrigine in typical absence epilepsy Brain Dev 21 1999 303-306
23. A. Nicolson R.E. Appleton D.W. Chadwick D.F. Smith The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies J Neurol Neurosurg Psychiatr 75 2004 75-79
24. P.L. Timmings A. Richens Efficacy of lamotrigine as monotherapy for juvenile myoclonic epilepsy: Pilot study results Epilepsia 34 Suppl. 2 1993 160 [Abstract]
25. E.J. Carrazana S.D. Wheeler Exacerbation of juvenile myoclonic epilepsy with lamotrigine Neurology 56 2001 1424 [Letter]
26. G. Morris J. Schimschock A. Vuong Broad-spectrum activity of lamotrigine monotherapy in patients with juvenile myoclonic epilepsy Epilepsia 41 Suppl. 7 2000 92 [Abstract]
27. G.L. Morris A.E. Hammer R.P. Kustra J.A. Messenheimer Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: Results of an open-label study Epilepsy Behav 5 2004 509-512
28. A. Biraben H. Allain J.M. Scarabin S. Schück G. Edan Exacerbation of juvenile myoclonic epilepsy with lamotrigine Neurology 55 2000 1758 [Letter]
29. R. Guerrini C. Dravet P. Genton A. Belmonte A. Kaminska O. Dulac Lamotrigine and seizure aggravation in severe myoclonic epilepsy Epilepsia 39 1998 508-512
30. P. Genton When antiepileptic drugs aggravate epilepsy Brain Dev 22 2000 75-80
31. M.A. Mikati G.L. Holmes Lamotrigine in absence and generalized epilepsies J Child Neurol 12 Suppl. 1 1997 S29-S37